PW Medtech Group Limited submitted a Next Day Disclosure Return to the Hong Kong Stock Exchange on 10 September 2026 detailing its latest share repurchase activity and current share capital position.

Key points

• Latest on-market buyback: On 10 September 2026 the company repurchased 700,000 ordinary shares on the Exchange at prices ranging from HKD 0.965 to HKD 0.98, for a total consideration of HKD 0.68 million. • Ongoing cancellation process: Including this transaction, PW Medtech now holds 4.41 million shares pending cancellation—equivalent to 0.31% of the company’s issued share capital as at the 26 June 2026 mandate date. • Repurchase mandate headroom: The board is authorised to buy back up to 144.29 million shares; purchases to date utilise approximately 3.06% of the approved limit. • Share capital unchanged: Issued shares stood at 1.43 billion as at both 9 and 10 September 2026; repurchased shares remain outstanding until formal cancellation. • 30-day issuance lock-up: In line with HKEX rules, the company is subject to a moratorium on new share issues or treasury-share sales until 10 October 2026 following the latest repurchase.

The company confirmed that all repurchases were conducted in compliance with Hong Kong listing regulations and the terms of the shareholder mandate granted on 26 June 2026.